UNSPSC 51284010: Meclocycline

This classification denotes a tetracycline antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 23Q8M2HE6S. European Medicines Agency schedules Meclocycline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08677MIG. Meclocycline generally arises in the molecular formula C22H21CLN2O8. The term MECLOCYCLINE is an International Non-Proprietary Name or INN. MECLOCYCLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule meclocycline under HS 29413000 and SITC 54133. As of Q4 2014, MECLOCYCLINE remains the US FDA Preferred Term for this commodity. Meclocycline bears US NLM identifiers UMLS ID C0065841 and NCI Concept Code C61825. SMILES: CLC1C2C(=C)C3C(O)C4C(O)(C(=O)C3=C(O)C2C(O)CC1)C(=O)/C(=C(\O)N)C(=O)C4N(C)C.

UNSPSC 51284010 Meclocycline, a Commodity code, nominally describes a specific antibiotic, but recent state and local contract activity under this code shows no direct solicitation for meclocycline itself. Instead, the code has been applied to a broader range of pharmaceutical and medical supply procurements, including naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, and medical and first aid supplies for emergency response. State and local governments are using this code to solicit therapeutic pharmaceuticals, emergency-response medications, and related medical consumables through competitive bidding processes. Issuing bodies include county health departments (Seminole County, Florida), state pharmacy benefit programs (Texas Health and Human Services Commission), municipal fire departments (City of Tampa Fire Department Rescue Division), and regional cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The solicitations span health departments seeking community health supplies, state HHS agencies exploring direct-to-manufacturer prescription programs, municipal emergency services acquiring rescue-division consumables, and multistate cooperatives establishing pharmaceutical supply contracts for member jurisdictions.

Recent activity concentrates in Florida, Texas, and Minnesota, with broader participation across cooperative purchasing arrangements that span multiple states and member jurisdictions. Representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries (due July 26, 2023), the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs (posted April 3, 2026), the City of Tampa's IFB for 169 line items of medical and first aid supplies for its Fire Department Rescue Division with an estimated contract amount of $700,000.00 and a Small Local Business Enterprise set-aside (due March 13, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products across participating state and local facilities (proposals due March 26, 2026). The mismatch between the code's nominal scope and the actual solicitations suggests the code may be incorrectly tagged in procurement systems, or the category has been broadened in state and local databases to capture pharmaceutical procurement more generally.